TEVA
Stock Details
TEVA is Teva Pharmaceutical Industries Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 9.31$. Average daily volumn in 3 months 13.28M. Market cap 9.22B
Stock symbol : TEVA. Exchange : NYSE. Currency : USD Lastest price : 8.62$. Total volume : 4.92M. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Teva Pharmaceutical Industries Limited (TEVA)
Last Price
8.62$Change
0.40Volume
4.92M
| Previous Close | 8.23 |
| Open | 8.40 |
| Day Range | 8.38-8.69 |
| Bid | 8.65 x 4k |
| Ask | 8.66 x 800 |
| Volume | 4.92M |
| Average Volume | 13.28M |
| Market Cap | 9.22B |
| Beta | 1.27 |
| 52 Week Range | 6.78-11.34 |
| Trailing P/E | N/A |
| Foward P/E | 3.38 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | 2017-11-27 |
Financial Details
Organization
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells ac... tive pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Market Cap:
9.22BRevenue:
15.88BTotal Assets:
47.67BTotal Cash:
2.17B
News about "Teva Pharmaceutical Industries Limited"
Teva Pharmaceutical Industries Breaks Above 200-Day Moving Average - Bullish for TEVA
Source from : Nasdaq - 8 hours ago
In trading on Tuesday, shares of Teva Pharmaceutical Industries Ltd (Symbol: TEVA) crossed above their 200 day moving average of $8.61, changing hands as high as $8.65 per share. Teva Pharmaceutical ...See details»
Raymond James Trust N.A. Sells 1,526 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Source from : Defense World - 5 days ago
Raymond James Trust N.A. decreased its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Rating) by 5.1% in the second quarter, according to the company in its most recent ...See details»
Teva reaches settlement with Georgia over price fixing claims
Source from : NJBIZ - 1 days ago
Teva Pharmaceuticals reached an agreement with the state of Georgia to settle price-fixing claims against the pharmaceutical company.See details»
Teva Reaches Agreement With Georgia to Settle the State’s Price Fixing Claims
Source from : YAHOO!Finance - 4 days ago
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has reached an agreement with the Attorney General (AG) of Georgia to settle the state’s ...See details»
Teva To Pay $3.346 Mln To Settle Georgia's Price Fixing Claims
Source from : Business Insider - 4 days ago
Teva Pharmaceuticals, a US arm of Israeli drug maker Teva Pharmaceutical Industries Ltd. (TEVA), said on Friday that it will pay ...See details»
New Suit - Class Action
Source from : Law - 3 month ago
Counsel have not yet appeared for the defendants. The case is 2:21-cv-00477, King County et al v. Teva Pharmaceutical Industries Ltd et al.See details»
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Source from : Yahoo News - 16 days ago
TEL AVIV (Reuters) - Teva Pharmaceutical Industries expects to finalise an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while ...See details»
Teva Launches Honestly HD Website to Provide People Living With Huntington's Disease (HD) Information, Inspiration and Resources on HD Chorea
Source from : Stockhouse - 8 days ago
CloseCurlyDoubleQuote; Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a ...See details»
Teva: Studies Show Efficacy Of Fremanezumab In Patients With Migraine And Major Depressive Disorder
Source from : Business Insider - 26 days ago
(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) reported the results of two studies, which demonstrated the efficacy of AJOVY or fremanezumab in migraine patients who also experience ...See details»
25 Biggest Pharmaceutical Companies in the World A Year Ago
Source from : Insider Monkey - 28 days ago
Market Capitalization as of September 11, 2021: $10.3 billion Market Capitalization as of September 02, 2022: $10 billion Teva Pharmaceutical Industries Limited (NYSE: TEVA) is the 25 th on the ...See details»
Respiratory Inhalers Market : Analysis by Size, Share Trends, Future Growth, Emerging Trends, Qualitative Outlook and Global Forecast to 2028
Source from : MarketWatch - 1 days ago
Respiratory Inhalers Market [1.3% CAGR] 2022 Touching New Heights, Advancing Technologies Helps Prominent Players ...See details»
Acute Bacterial Skin and Skin Structure Infections Market to Surpass US$ 5,512.1 Mn by 2030
Source from : Medgadget - 11 hours ago
Moreover, market players are participating in research and advancement activities for the improvement of new drugs in the treatment of global acute bacterial skin and skin structure infections market.See details»
Studies Show Effectiveness of AJOVY® (fremanezumab) for Treatment of Migraine in Patients With Co-morbid Depression
Source from : Stockhouse - 26 days ago
Teva Pharmaceutical Industries Ltd. today announces the results of two studies1,2 presented at the Migraine Trust International Symposium (MTIS) in London, UK, which demonstrate the efficacy of AJOVY ...See details»
Diuretic Drugs Market to Record a CAGR of 5.44%, Increasing Incidence of Hypertension Among People to Drive Growth - Technavio
Source from : Yahoo - 5 days ago
The report "Diuretic Drugs Market by Product Type and Geography - Forecast and Analysis 2022-2026" has been added to Technavio's offerings. The market size is anticipated to grow by USD 95.64 million ...See details»